UnitedHealth Group saw its price target slashed from $640 to $510 by Robert W. Baird, despite maintaining an “outperform” ...

The Manufacturers Life Insurance Company reduced its Home Depot holdings by 4.7% in Q4, selling 38,498 shares. This left the ...

Eli Lilly’s Q1 earnings smashed expectations, fueled by surging demand for its blockbuster drugs Zepbound and Mounjaro. The ...

Investors are eagerly awaiting Berkshire Hathaway’s Q1 results to find out if Warren Buffett dipped into his record $334 ...

Mission Creek Capital Partners Inc. jumped into the financial fray by acquiring 21,444 shares of Bank of America, a stake ...

Apple shares dipped nearly 3% after CEO Tim Cook revealed a looming $900 million tariff toll this quarter and scaled down ...

Analysts at Cantor Fitzgerald shaved a whopping two cents off their FY2025 EPS forecast for AbbVie, from $12.33 to $12.31, ...

Merck & Co. is caught in the middle of Wall Street's version of a group chat disagreement. Analysts gave it a “Moderate Buy” ...

Salesforce continues charming Wall Street, as Westpark Capital reaffirmed its "buy" rating and pegged a $320 target, hinting ...

Nebula Research & Development LLC more than doubled its Chevron holdings in Q4, snapping up 5,165 additional shares worth ...

Southern Copper just got a lukewarm upgrade from HSBC Global Res, shifting from “moderate sell” to “hold”—which is basically ...

Alphabet, despite a tech giant glow-up, has underperformed the broader market, dropping 16.1% year-to-date while others ...